SVB Leerink Downgrades Calithera Biosciences (CALA) to Market Perform

January 4, 2021 4:43 PM EST Send to a Friend
SVB Leerink analyst Jonathan Chang downgraded Calithera Biosciences (NASDAQ: CALA) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login